Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients
dc.authorid | Tuğba Kemaloğlu Öz / 0000-0003-1168-8237 | |
dc.authorscopusid | Tuğba Kemaloğlu Öz / 55804564100 | |
dc.authorwosid | Tuğba Kemaloğlu Öz / HXI-6000-2023 | |
dc.contributor.author | Kemaloğlu Öz, Tuğba | |
dc.contributor.author | Abdelnabi, Mahmoud | |
dc.contributor.author | Fiore, Corrado | |
dc.contributor.author | Almaghraby, Abdallah | |
dc.contributor.author | Cihan, Deniz | |
dc.contributor.author | Babazade, Nigar | |
dc.date.accessioned | 2021-11-10T13:33:24Z | |
dc.date.available | 2021-11-10T13:33:24Z | |
dc.date.issued | 2021 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | BACKGROUND: Three-dimensional (3D) echocardiography and 3D strain parameters have been used for a comprehensive quantitative assessment of left ventricular (LV) myocardial dynamics. So far, there are no data on sacubitril/valsartan effects on cardiac functions and LV reverse remodeling using 3D echocardiography. This study aimed to evaluate the effects of sacubitril/valsartan on the LV functions using two-dimensional (2D) echocardiography, 3D echocardiography, and the 3D strain parameters. METHODS: A single-center prospective cohort study which included 100 heart failure with reduced ejection fraction (HFrEF) patients with guidelines-approved indications for sacubitril/valsartan treatment. Patients received a short course (3-month) of sacubitril/valsartan. 3-month follow-up 2D, 3D echocardiographic parameters, and 3D strain were compared to baseline parameters. RESULTS: The results of the study revealed a significant improvement in left ventricular dynamic functions at 3-month follow-up with an improvement in left ventricular systolic function (mean left ventricular ejection fraction (LVEF) increased from 27.65 ± 4.98% to 32.89 ± 6.03%, P<0.001). Comparison of HFrEF patients with ischemic and non-ischemic etiologies showed that echocardiographic parameters significantly improved in both groups after 3 months of sacubitril/valsartan treatment. There was no statistically significant difference between both groups regarding echocardiographic parameters at baseline and 3-month follow-up. CONCLUSIONS: In a single-center prospective observational cohort study evaluating the effects of short-term (3-month course) sacubitril/valsartan treatment on LV dynamics assessed by 3D echocardiography and 3D strain, sacubitril/valsartan was associated with a significant improvement of LV systolic functions and reverse remodeling effects in both ischemic and non-ischemic HFrEF patients. | en_US |
dc.identifier.citation | Öz, T. K., Abdelnabi, M., Fiore, C., Almaghraby, A., Cihan, D., Babazade, N., Haseeb Raza Naqvi, S., Omar, B., & Dağdeviren, B. (2021). Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients. Minerva cardiology and angiology, 10.23736/S2724-5683.21.05802-6. Advance online publication. https://doi.org/10.23736/S2724-5683.21.05802-6 | en_US |
dc.identifier.doi | 10.23736/S2724-5683.21.05802-6 | en_US |
dc.identifier.pmid | 34713680 | en_US |
dc.identifier.scopus | 2-s2.0-85135419373 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.23736/S2724-5683.21.05802-6 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2215 | |
dc.identifier.wos | WOS:000968189300004 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Kemaloğlu Öz, Tuğba | |
dc.language.iso | en | en_US |
dc.publisher | MedGen | en_US |
dc.relation.ispartof | Minerva Cardiology and Angiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Heart Failure With Reduced Ejection Fraction (HFrEF) | en_US |
dc.subject | Sacubitril/valsartan | en_US |
dc.subject | 3D Echocardiography | en_US |
dc.subject | 3D Stain | en_US |
dc.subject | Ventricular Remodeling | en_US |
dc.title | Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients | en_US |
dc.type | Article | en_US |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: